Costco Introduced a Controversial Perk Last Year -- and It Plans to Follow This Up With 4 New Benefits in 2026

Costco is rolling out four member-focused initiatives in 2026—mandatory digital membership scanning at food courts, its first stand-alone gas station in Mission Viejo, expanded pre-scan checkout technology (reducing checkout times by up to 20%), and prescription price-transparency via a Navitus cost-plus PBM partnership announced Aug. 5, 2025. The moves follow a 2024 membership fee increase ($65 for Gold Star/Business, $130 for Executive) and underscore the economic leverage of memberships: as of fiscal Q1 (ended Nov. 23, 2025) 74.3% of net sales came from the 48.8% of members who are Executives, supporting high-margin operating income and member-retention economics amid a global retail market Mordor Intelligence projects to grow from $29.8T (2026) to $41.5T by 2031.

Analysis

Market structure: Costco (COST) is the clear winner — tighter membership enforcement, expanded pre-scan tech, a standalone gas experiment and PBM cost‑plus transparency deepen its high‑margin membership moat and raise ARPU; 48.8% of members producing 74.3% of sales implies any change in Executive renewal materially moves sales. Competitors (WMT, AMZN) face pressure to match loyalty/perk economics or cede higher‑margin basket business; regional gas stations and non‑member food vendors are losers. Commodity effect on crude is negligible but narrower retail margins could compress gas retail spreads locally.

Risk profile: Near term (days–weeks) execution risk from tech rollouts and guest friction; short term (1–3 months) investor focus will be on membership renewal stats and Q2 sales; long term (3–24 months) benefits hinge on retention of Executive cohort and pharmacy uptake from the Navitus tie‑up. Tail risks: member backlash, regulatory scrutiny on member‑only privileges, or failed gas rollouts. A 3–5 percentage‑point decline in Executive renewal would be high‑impact.

Trade implications: Favor COST overweight vs. general retail; use directional (9–15 month) call spreads or LEAPs to capture membership monetization with controlled capital. Relative value: long COST vs. short WMT/AMZN to express moat expansion. Options: buy 6–12 month call spreads into earnings and sell covered calls on rallies; buy protective puts if renewal rate drops >200 bps.

Contrarian angles: Consensus understates churn sensitivity — heavy reliance on Executives is a concentration risk; technology/scan enforcement may alienate casual shoppers and slow visit frequency. Historical parallel: membership pivots (e.g., premium club strategies) can boost margin but cap penetration; monitor renewal % and Exec mix closely as the true valuation lever.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in COST over the next 30 days; prefer capital‑efficient 9–15 month call spreads (e.g., Jan–Mar 2027 expiries, buy ATM+5–10% call, sell ATM+25–35% call) targeting +15–25% upside in 9–12 months; set stop‑loss to trim half position if COST drops 10% from entry.
• Initiate a relative‑value pair: long COST (1.5–2.0% weight) and short WMT (0.8–1.2%) to express membership moat; close or rebalance if the COST/WMT spread narrows by >5% in 60 days or if COST Executive share falls under 46%.
• Enter an options hedge: buy 4–6 month puts on COST (one‑to‑one notional to 25–50% of equity exposure) if membership renewal guidance disappoints by >200 bps or if same‑store sales miss consensus; alternatively sell covered calls after a 10% rally to monetize premium.
• Reallocate 3–5% from discretionary retail longs into defensive consumer staples and select pharmacy beneficiaries (pharmacy transparency winners) over the next 90 days; add to COST exposure if membership renewal stays >=90% and Executive cohort revenue share remains >48% at next quarterly report.